MediciNova, Inc.

MediciNova, Inc.verified

MNOV

Price:

$2.055

Market Cap:

$100.79M

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of ...[Read more]

Industry

Biotechnology

IPO Date

2006-12-08

Stock Exchange

NASDAQ

Ticker

MNOV

The ROE as of December 2024 (TTM) for MediciNova, Inc. (MNOV) is -20.70%

According to MediciNova, Inc.’s latest financial reports and current stock price. The company's current ROE is -20.70%. This represents a change of 368.89% compared to the average of -4.42% of the last 4 quarters.

MediciNova, Inc. (MNOV) Historical ROE (quarterly & annually)

How has MNOV ROE performed in the past?

The mean historical ROE of MediciNova, Inc. over the last ten years is -23.18%. The current -20.70% ROE has changed -10.68% with respect to the historical average. Over the past ten years (40 quarters), MNOV's ROE was at its highest in in the March 2021 quarter at -0.20%. The ROE was at its lowest in in the June 2015 quarter at -11.47%.

Quarterly (TTM)
Annual

Average

-23.18%

Median

-20.05%

Minimum

-41.78%

Maximum

-12.11%

MediciNova, Inc. (MNOV) ROE by Quarter and Year

Discovering the peaks and valleys of MediciNova, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 163.67%

Maximum Annual ROE = -12.11%

Minimum Annual Increase = -37.65%

Minimum Annual ROE = -41.78%

Quarterly (TTM)
Annual
YearROEChange
2023-13.74%-31.40%
2022-20.03%65.38%
2021-12.11%-37.65%
2020-19.42%12.40%
2019-17.28%-13.92%
2018-20.07%-30.51%
2017-28.89%-8.19%
2016-31.47%16.52%
2015-27.01%-35.36%
2014-41.78%163.67%

MediciNova, Inc. (MNOV) Average ROE

How has MNOV ROE performed in the past?

The current ROE of MediciNova, Inc. (MNOV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-15.29%

5-year avg

-16.52%

10-year avg

-23.18%

MediciNova, Inc. (MNOV) ROE vs. Peers

How is MNOV’s ROE compared to its peers?

MediciNova, Inc.’s ROE is greater than Aerovate Therapeutics, Inc. (-90.19%), greater than Adagene Inc. (-50.10%), greater than Acrivon Therapeutics, Inc. Common Stock (-47.95%), greater than Rezolute, Inc. (-69.83%), greater than AN2 Therapeutics, Inc. (-57.63%), less than Eliem Therapeutics, Inc. (0%), less than Molecular Partners AG (0%), greater than Champions Oncology, Inc. (-39.16%), less than Cyteir Therapeutics, Inc. (66.22%), greater than Anebulo Pharmaceuticals, Inc. (-9.44%), greater than PMV Pharmaceuticals, Inc. (-184.40%), greater than Pharvaris N.V. (-24.20%), greater than PepGen Inc. (-38.27%), greater than null (-60.17%),

Build a custom stock screener for MediciNova, Inc. (MNOV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediciNova, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediciNova, Inc. (MNOV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediciNova, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is MediciNova, Inc.'s ROE?

How is the ROE calculated for MediciNova, Inc. (MNOV)?

What is the highest ROE for MediciNova, Inc. (MNOV)?

What is the 3-year average ROE for MediciNova, Inc. (MNOV)?

What is the 5-year average ROE for MediciNova, Inc. (MNOV)?

How does the current ROE for MediciNova, Inc. (MNOV) compare to its historical average?